HK Stock MarketDetailed Quotes
02315 BIOCYTOGEN-B
- 6.100
- +0.500+8.93%
Market Closed Nov 15 16:08 CST
2.44BMarket Cap-9118P/E (TTM)
6.100High5.690Low177.50KVolume6.100Open5.600Pre Close1.05MTurnover0.16%Turnover RatioLossP/E (Static)399.40MShares13.50052wk High3.01P/B675.77MFloat Cap5.60052wk Low--Dividend TTM110.78MShs Float28.800Historical High--Dividend LFY7.32%Amplitude5.600Historical Low5.893Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
BIOCYTOGEN-B Key Stats
EPS
According to the latest financial report of BIOCYTOGEN-B, the latest earnings per share (TTM) for the company is -0.14. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out BIOCYTOGEN-B's latest financial report to see how much their book value per share (BVPS) is currently at 2.03.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BIOCYTOGEN-B shows that the company's current ratio is 1.34, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BIOCYTOGEN-B, the quick ratio is 1.33, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of BIOCYTOGEN-B? The latest ROE figure is -6.62%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BIOCYTOGEN-B, the total asset return on investment (ROA) is -2.07%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BIOCYTOGEN-B's latest financial report to see how their gross margin is doing - currently at 74.42%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BIOCYTOGEN-B, the net profit margin is -12.34%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data